Silence Therapeutics plc Current Income Tax Expense (Benefit)
Silence Therapeutics plc (SLNCF) reported Current Income Tax Expense (Benefit) of $11.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-05
- Silence Therapeutics plc current income tax expense (benefit) for fiscal 2025 was $11.00K, a 98.70% decline from fiscal 2024.
- Silence Therapeutics plc current income tax expense (benefit) for fiscal 2024 was $845.00K, a 11.61% decline from fiscal 2023.
- Silence Therapeutics plc current income tax expense (benefit) for fiscal 2023 was $956.00K, a 38.95% increase from fiscal 2022.
- Silence Therapeutics plc current income tax expense (benefit) for fiscal 2022 was $688.00K.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $11.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $845.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $956.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $688.00K 10-K · filed 2025-02-27 |